Celltrion "CHMP Recommends Approval for COVID-19 Treatment Sales"
[Asia Economy Reporter Ji Yeon-jin] Celltrion announced on the 12th that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency has recommended the approval of sales for its COVID-19 treatment (CT-P59).
Hot Picks Today
!["Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"](https://cwcontent.asiae.co.kr/asiaresize/93/2026051507261063923_1778797570.png)
"Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- While Everyone Focused on Samsung and Nix, This Company Soared 50%... Hit Record Highs for 4 Days [Weekend Money]
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- "Uneducated Person" to Management Office Employee... Why Was the Resident Acquitted?
- "Target Price Set at 970,000 Won"... Top Investors Already Watching, Only an 'Uptrend' Remains [Weekend Money]
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
